Simulating Titration to Goal Clinical Trials with Statins

References

• Akaike , H. 1974 . A new look at statistical model identification . IEEE Trans. Automatic Control , AU-19 : 716 – 722 .
   Web of Science ®Google Scholar
• Ballantyne , C. M. 1998 . Low-density lipoproteins and risk for coronary artery disease . Am. J. Cardiol. , 82 : 3Q – 12Q . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   Web of Science ®Google Scholar
• Bargter , P. et al. 2001 . Lipid management guidelines – 2001 . Med. J. Australia , 175 Supplement
   Web of Science ®Google Scholar
• Berry , D. A. , Berry , S. M. , McKellar , J. and Pearson , T. A. 2003 . Comparison of the dose-response relationships of 2 lipid-lowering agents. A Bayesian meta- analysis . American Heart Journal , 145 : 1036 – 1045 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Box , G. E. P. and Cox , D. R. 1964 . An analysis of transformations (with discussion) . J. R. Statist. Soc. B , 26 : 211 – 252 .
   Google Scholar
• Brown , W. V. , Bays , H. E. , Hassman , D. R. , McKenney , J. , Chitra , R. , Hutchinson , H. and Miller , E. 2002 . Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial . Am. Heart J. , 144 ( 6 ) : 1036 – 1043 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Davidson , M. , Mckenney , J. , Stein , E. , Schrott , H. , Bakker-Arkema , R. , Fayyad , R. and Black , D. 1997 . Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia . Am. J. Cardiol. , 79 : 1475 – 1481 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Davidson , M. , Ma , P. , Stein , E. A. , Gotto , A. M. , Raza , A. , Chitra , R. and Hutchinson , H. 2002 . Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia . Am. J. Cardiol. , 89 : 268 – 275 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Downs , J. R. , Clearfield , M. and Weis , S. et al. 1998 . Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS . J. Am. Med. Assoc. , 279 : 1615 – 1622 . [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Durrington , P. 2002 . The human and economic costs of undertreatment with statins . Int. J. Clin. Pract. , 56 ( 5 ) : 357 – 368 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fisher , R. A. 1973 . Statistical Methods and Scientific Inference Hafner Press .
   Google Scholar
• Fredrickson , D. S. , Levy , R. I. and Lees , R. S. 1967 . Fat transport in lipoproteins – an integrated approach to mechanisms and disorders . New England J. Med. , 276 : 34 – 42 . 94–103, 148–156, 215–225, 273–281
   PubMed Web of Science ®Google Scholar
• 2000 . French Agency for the Safety of Health Products. The therapeutic management of dislipidaemia patients
   Google Scholar
• Knopp , R. H. 1999 . Drug treatment of lipid disorders . New England J. Med. , 341 : 498 – 511 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kong , S. X. , Crawford , S. Y. , Gandhi , S. K. , Seeger , J. D. , Schumock , G. T. , Lam , N. P. , Stubbings , J. A. and Schoen , M. D. 1997 . Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the treatment of patient with hypercholesterolemia: A meta-analysis of clinical trials . Clin. Ther. , 19 ( 4 ) : 772 – 797 . [CROSSREF]
   Web of Science ®Google Scholar
• MacLaine , G. D. H. and Patel , H. 2001 . A cost-effectiveness model of alternative statins to achieve goal LDL-cholesterol levels . Int. J. Clin. Pract. , 55 ( 4 ) : 243 – 249 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mardia , K. V. , Kent , J. T. and Bibby , J. M. 1979 . Multivariate Analysis Academic Press .
   Google Scholar
• 2002 . Medical Research Council/British Heart Foundation Heart Protection Study Collaborative Group. Heart Protection Study of cholesterol lowering with simvastatin in 20,536 of high risk individuals: a randomised placebocontrolled trial. Lancet. 360:7–22M
   Google Scholar
• 1993 . National Institutes of Health. Detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). NIH publication no. 93-3095
   Google Scholar
• 2001 . National Institutes of Health. Detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). NIH publication no. 01-3305
   Google Scholar
• 2000 . National Service Framework for Coronary Heart Disease, Department of Health
   Google Scholar
• Olsson , A. G. , Istad , H. , Luurila , O. , Ose , L. , Stender , S. , Tuomilehto , J. , Wiklund , O. , Southworth , H. , Pears , J. and Wilpshaar , J. W. 2002 . Effects of rosuvastatin and atorvastatin over 52 weeks of treatment in hypercholesterolemic patients . Am. Heart J. , 144 ( 6 ) : 1044 – 1051 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Paoletti , R. , Fahmy , M. , Mahla , G. , Mizan , J. and Southworth , H. 2002 . Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: A randomized double-blind trial . J. Cardiovasc. Risk , 8 : 383 – 390 . [CSA] [CROSSREF]
   Google Scholar
• Royall , R. 1997 . Statistical Evidence: A Likelihood Paradigm Chapman & Hall/CRC .
   Google Scholar
• Sacks , F. M. , Pfeffer , M. A. and Moye , L. A. et al. 1996 . The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol level . New England J. Med. , 335 : 1001 – 1009 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schneck , D. W. , Knopp , R. H. , Ballantyne , C. M. , McPherson , R. , Chitra , R. and Simonson , S. G. 2003 . Comparison of rosuvastatin and atorvastatin across their dose-ranges in patients with hypercholesterolemia . Am. J. Cardiol. , 91 : 33 – 41 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schwartz , G. et al. 2004 . American Journal of Cardiology, In press
   Google Scholar
• Senn , S. 1997 . Statistical Issues in Drug Development John Wiley & Sons .
   Google Scholar
• Shepherd , J. , Cobbe , S. M. and Ford , I. et al. 1995 . Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia . New England J. Med. , 333 : 1301 – 1307 . [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• 1994 . The Scandinavian Simvastatin Survival Study group. Randomised trial of cholesterol lowering in 444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study Lancet 344:1383–1389
   Google Scholar
• Venables , W. N. and Ripley , B. D. 2002 . Modern Applied Statistics with S , 4th ed. Springer .
   Google Scholar
• Wallis , E. J. , Ramsay , L. E. , Ul Haq , I. , Ghahramani , P. , Jackson , P. R. , Rowland-Yeo , K. and Yeo , W. W. 2000 . Coronary and cardiovascular risk estimation for primary prevention: Validation of a new Sheffield table in the 1995 Scottish health survey population . Br. Med. J. , 320 : 671 – 676 .
   PubMed Web of Science ®Google Scholar
• Wood , D. , De Backer , G. , Faergeman , O. , Graham , I. , Mancia , G. and Pyorala , A. 1998 . Task force report: Prevention of coronary heart disease in clinical practice. Recommendation of the second joint task force of European and other societies on coronary prevention . Eur. Heart J. , 19 : 1434 – 1503 . [CROSSREF]
   PubMed Web of Science ®Google Scholar